Foresite Life Sciences Corp. (FSAC)

Foresite Life Sciences was planning to go public, but the IPO has been withdrawn.
Stock Price: $10.00
Confirmed IPO price
Chart not available yet
Data will show when the stock starts trading.
Market Cap 319.50M
Revenue (ttm) n/a
Net Income (ttm) n/a
Shares Out 31.95M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Open n/a
Previous Close n/a
Day's Range n/a
52-Week Range n/a
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About FSAC

Foresite Life Sciences is a newly organized blank check company incorporated for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. We intend to capitalize on our management team’s background and experience to identify promising opportunities in the biotechnology and life science infrastructure sectors. We believe that there is an especially favorable opportunity for investors in (i) preclinical to pre-commercial companies wi... [Read more...]

Industry Blank Check / SPAC
Founded 2021
CEO Jim Tananbaum
Country United States
Stock Exchange NASDAQ
Ticker Symbol FSAC
Full Company Profile


Foresite Life Sciences IPO Registration Document (S-1)

Foresite Life Sciences Corp. has filed to go public with an IPO on the NASDAQ.